Cargando…

Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide

BACKGROUND: This analysis aims to evaluate health-related quality of life (HrQoL) (primary outcome for this analysis), nausea and vomiting, and pain in patients with inoperable malignant bowel obstruction (IMBO) due to cancer or its treatments randomised to standardised therapies plus octreotide or...

Descripción completa

Detalles Bibliográficos
Autores principales: McCaffrey, Nikki, Asser, Tegan, Fazekas, Belinda, Muircroft, Wendy, Agar, Meera, Clark, Katherine, Eckermann, Simon, Lee, Jessica, Joshi, Rohit, Allcroft, Peter, Sheehan, Caitlin, Currow, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603764/
https://www.ncbi.nlm.nih.gov/pubmed/33129304
http://dx.doi.org/10.1186/s12885-020-07549-y

Ejemplares similares